Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
73%
Ph phase_2
1
9%
Ph phase_1
2
18%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (18.2%)
Phase 21 (9.1%)
N/A8 (72.7%)

Trials by Status

completed873%
unknown327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11